Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yi Qi Jian Pi + Qu Tan Hua Zhuo is a Traditional Chinese Medicine (TCM) granule formulation composed of eight herbal ingredients: *Astragalus membranaceus* (HuangQi), *Codonopsis pilosula* (DangShen), *Atractylodes macrocephala* (BaiZhu), *Poria cocos* (FuLing), *Rhizoma pinelliae Preparata* (QingBanXia), *Trichosanthes kirilowii* (GuaLou), *Salvia miltiorrhiza* (DanShen), and *Glycyrrhiza uralensis* (ZhiGanCao). It is being investigated in randomized controlled trials for the treatment of stable angina pectoris, specifically for patients presenting with the TCM syndrome of Spleen deficiency generating phlegm. The formulation aims to tonify Qi, strengthen the Spleen, and resolve phlegm and turbidity. It is typically administered as an integrative treatment alongside conventional medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yi qi jian pi + qu tan hua zhuo.